remaining patients without dissemination were used as the control group. This number provided adequate statistical power for analysis. Our series was limited to 16 cases of disseminated lesions. As the control/case ratio increases from 2:1 to 3:1 or greater, the information that the additional number of controls provides is limited. We compared the control population analyzed in this report to the remainder of nondisseminated cases and found no difference in age, sex, or histology. The group with nondisseminated lesions consisted of 23 patients with primary spinal cord tumors and five patients with primary intracranial tumors.
A retrospective review of the medical records was performed to determine the patient's age, gender, duration of symptoms prior to diagnosis, time interval from diagnosis to dissemination, the extent and number of surgical resections, and the use of adjuvant therapy.
Pathological Evaluation
All histological slides were graded by a single neuropathologist (D.Z.) as low-grade, high-grade, or myxopapillary ependymoma. The sections were evaluated for the presence of mitotic figures, vascular hyperplasia, and necrosis. Only when all three of these characteristics were present was a tumor designated as high grade. 3 All tumor specimens were analyzed by immunohistochemistry for a nuclear activation antigen (Ki-67) to determine the cellular proliferation index. This was accomplished using the mouse monoclonal antibody MIB-1 (Immunotech, Westbrook, ME), which recognizes the Ki-67 antigen in formalin-fixed, paraffin-embedded tissues. The Ki-67 nuclear antigen is expressed in each phase of the cell cycle except the G 0 phase and serves as a marker for cellular proliferation. 1, 2, 14, 17 For each specimen, 4 m m-thick sections were cut from paraffin blocks, deparaffinized, rehydrated, and stained by standard methods using the avidinbiotin-horseradish peroxidase complex to localize the antibody bound to antigen (Fig. 1) .
The MIB-1 nuclear staining was automated and quantitated on an image analysis system (SAMBA 4000 Immuno Software Program; Imaging Products International, Chantilly, VA). For each specimen, 10 fields were analyzed at 3 40 magnification and stained tumor cells were counted. The percentage of stained cells was then determined.
Statistical Analysis
Statistical associations were assessed using a two-tailed test. A probability value of 0.05 was considered statistically significant. All statistical computations were performed using a statistical analysis program (JMP Version 3.0; SAS Institute, Inc., Cary, NC).
The statistical procedure used for evaluating the difference between the medians was the nonparametric Mann- Whitney. 34 Chi-square tests were performed to compare categorical variables. 11 A chi-square analysis was used to evaluate the association between extent of resection and tumor dissemination. Multivariate analysis was performed using the Cox proportional hazards model. 32 To simplify the multivariate model, we used the univariate methods to reduce the number of variables that were ultimately tested in the multivariate model. Only those variables that were significant in the univariate models were included in the multivariate analysis. The multivariate model subsequently determined which of these variables had the most profound effect on the endpoint, whether that was time to dissemination or survival. Risk ratios were calculated for each of the various clinical and pathological criteria with respect to the time to dissemination. Kaplan-Meier survival analysis was used to evaluate time to dissemination for extent of resection and histology.
Results

Clinical and Surgical Characteristics
A summary of the patients' clinical and surgical characteristics is shown in Table 1 . The groups with disseminated and nondisseminated disease did not differ in regard to gender. The group with disseminated lesions was significantly younger than the group with nondisseminated lesions. The mean age for the group with disseminated † Statistical significance at p Յ 0.05. ‡ The radiographic location of the primary lesion at the initial presentation.
§ The mean and range in months of the duration of symptoms prior to the initial diagnosis.
The extent of resection of the initial surgery. This is divided into three categories based on the surgeon's operative estimates and the postoperative magnetic resonance image. disease was 16.8 years, whereas that for the group with nondisseminated disease was 28.3 years (p = 0.02). There was a strong suggestion that the group with dissemination had a shorter duration of symptoms prior to initial presentation. The group with dissemination had a mean duration of symptoms of 10 months whereas in the group without dissemination the duration was 18 months (p = 0.09). In addition, the mean duration of symptoms for disseminated intracranial ependymomas was 1 month, versus 14 months for disseminated spinal tumors (p = 0.003, MannWhitney). Clinical symptoms included headaches, nausea and vomiting, motor deficits, sensory loss, and gait difficulties. There was no difference between the groups with regard to primary tumor location (p = 0.3, chi-square test).
All patients underwent operation at the time of or very close to the time of diagnosis. The two groups differed significantly with regard to the extent of initial surgical resection. There were two patients who presented with dissemination at the time of diagnosis and were excluded from the analysis concerning extent of initial resection; however, they were included in all other analyses. The extent of resection was determined by the operative estimate of resection and by the postoperative magnetic resonance image. The group with disseminated disease included 29% of patients with gross-total tumor resections, whereas the group without dissemination included 68% of patients with gross-total resections (p = 0.015, chisquare). Kaplan-Meier analysis was used to compare the time to dissemination in patients with and without total tumor resections (Fig. 2 upper) . At 5-year follow-up review, only 4% of the patients with gross-total resections suffered dissemination compared to 44% of patients without gross-total resections (log-rank p = 0.03). The Kaplan-Meier analysis was limited to 6 years because the small sample size beyond that time period made the analysis unstable statistically.
The mean number of reoperations in the group with disseminated disease was greater than that for nondisseminated tumors (1.15 vs. 0.6, p = 0.0001). However, the mean number of reoperations was significantly associated with the extent of the initial resection, and therefore seemed related to dissemination of the primary tumor.
Similarly, the use of adjuvant therapy after the initial surgical procedure appeared to have a significant association with dissemination (p = 0.024, chi-square). However, adjuvant therapy was more likely to be used in the setting of subtotal resection, and therefore was not independently related to disseminated disease. For example, 87% of patients undergoing gross-total resection did not receive subsequent adjuvant therapy, whereas 74% of patients with subtotal resections did receive adjuvant therapy (p = 0.0002, chi-square).
Tumor Histology and Proliferation Index
The groups differed significantly with regard to tumor histology. The histological data is summarized in Table 2 . Kaplan-Meier analysis was used to compare the time to dissemination for histological subtypes of ependymomas (Fig. 2 center) . At 5-year follow-up review, 66% of the high-grade tumors and 33% of the myxopapillary tumors had become disseminated, as opposed to only 8% of the low-grade tumors (log-rank p = 0.002). In addition, the high-grade lesions disseminated earlier than the myxopapillary tumors (Fig. 2 lower) . All high-grade tumors had disseminated by 3 years, whereas the myxopapillary tumors did not disseminate until at least 4 years. In the nondisseminated population, 82% of tumors were low grade on histological review.
As a whole, high-grade tumors exhibited a proliferation index of 21%, versus 2.4% and 1.6% for myxopapillary and low-grade tumors, respectively. There was no statistical difference between the myxopapillary and low-grade tumors; however, high-grade tumors exhibited a higher proliferation index than the other groups (p = 0.0003, chisquare). The overall mean proliferation index of the group without dissemination was 13.14%, whereas that for the group without dissemination was 2.06% (p = 0.02, Wilcoxon). The mean proliferation index for the group with disseminated intracranial disease (31%) was significantly higher when compared to the nondisseminated intracranial tumors (4.8%) (p = 0.014, Wilcoxon). In addition, there was a strong suggestion of a higher MIB-1 in the disseminated spinal ependymomas (5.19%) when compared to the nondisseminated spinal lesions (1.47%) (p = 0.106, Wilcoxon).
Multivariate Analysis
The Cox proportional hazards regression model was used to evaluate age, extent of resection, histology, and proliferation index simultaneously with respect to time to dissemination. Pathological grading had the most profound effect on the time to dissemination (p = 0.02, chi-square). Myxopapillary and high-grade ependymomas had hazards ratios of 3.6 and 5.6 for dissemination when compared to low-grade tumors (p = 0.008 for each chisquare). The extent of resection was strongly associated with dissemination; however, due to the small sample size, statistical significance was approached but not achieved (p = 0.07, chi-square). The proliferation index was not found to be significant in the multivariate analysis (p = 0.9, chi-square).
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Discussion
Epdendymomas are rare neoplasms accounting for less than 10% of primary CNS tumors. 9, 10, 15, 19, 22, 24, 35, 36, 38 Ependymomas are potentially curable tumors because they are amenable to complete surgical resection. 6, 9, 22, 38 Dissemination in the CNS and systemic metastasis have been reported previously in case studies and in large series in which they comprise a small fraction of cases. 21, 28, [36] [37] [38] [39] These studies have analyzed patient survival as their outcome and have not specifically addressed the question of dissemination. The rarity of disseminated ependymomas has precluded an adequate risk analysis.
Between 1986 and 1994, the senior author (F.J.E.) surgically treated 140 patients with CNS ependymoma. Of these, 16 patients have suffered from dissemination of their primary disease (11.4%). The incidence of dissemination for primary spinal disease was 12.5% and that for primary intracranial disease was 9.6%. This is similar to rates reported in previous studies in which the incidence of dissemination ranged from three to 11%.
13,21,26,36,38
Patient Characteristics
The patients developing disseminated disease were younger (16.8 years vs. 28.3 years). In addition, there was a suggestion that patients with dissemination had a shorter duration of symptoms (10 vs. 18 months). The younger age and shorter duration of symptoms at presentation suggests that tumors that disseminate are biologically distinct from tumors that present later in life.
Previous studies have shown a poor prognosis with regard to survival for intracranial ependymomas. 24 In this series, the primary tumor location was not significantly associated with tumor dissemination. Although intracranial ependymomas were not more likely to disseminate than spinal ependymomas, these patients did present with a much shorter duration of symptoms.
Surgical Resection
The extent of the initial surgical resection was highly significant with respect to dissemination. Of particular interest is the fact that 83% of the patients with gross-total tumor resections never developed disseminated disease, whereas 71% of the patients with subtotal resections demonstrated dissemination. The importance of total resection at the initial surgical attempt must be emphasized because a patient with residual tumor is 5.3 times more likely to suffer from disseminated disease eventually (p = 0.02, chi-square).
The prognostic importance of aggressive surgical resection for patient survival has been emphasized frequently. 6, 9, 16, 22, 38 There is a lower incidence of recurrence and a more favorable outcome with gross-total resection. Higher recurrence rates have been shown with incomplete resection of intramedullary spinal cord ependymomas, and long-term disease-free survival is best achieved with a total resection at the initial setting. However, dissemination potential was not specifically addressed in previous studies.
Ependymomas, in particular the spinal cord and supratentorial tumors, are amenable to complete surgical resection. These tumors are generally well circumscribed and tend to displace rather than infiltrate the surrounding neural tissue. There is usually a distinct tumor margin that allows for the development of a well-defined surgical plane. 5, 9 This is not necessarily the case for posterior fossa ependymomas, which are more hazardous to resect. Gross-total or en bloc resection is the desired goal of surgery. However, factors such as location, tumor infiltration, and the experience of the surgeon may preclude a gross-total removal.
Encapsulated tumors involving the cauda equina or filum terminale are potential candidates for en bloc resection. Sonneland, et al., 35 have reported that encapsulated myxopapillary tumors involving the filum terminale that are removed en bloc exhibit a lower proportion of dissemination (10%) than tumors that are removed piecemeal (19%). Thus, violation of the tumor capsule may lead to subsequent cerebrospinal fluid seeding and dissemination. This may be the mechanism of dissemination for some histologically benign tumors located in this region. In our disseminated population, none of the seven tumors involving the filum terminale or the cauda equina was resected en bloc.
Other aspects of patient treatment such as the number of reoperations on the primary tumor and the use of adjuvant therapy were not independently related to tumor dissemination, but were related to the extent of tumor resection. Hence, it was difficult to assess the role of the number of resections and adjuvant therapy with respect to dissemination due to the significant association of these variables with extent of surgical resection.
Tumor Histology
In contrast to other primary CNS tumors in which histological anaplasia usually corresponds to a greater degree of clinical malignancy, conflicting results have been found when correlating ependymoma histology with clinical prognosis. 12, 19, 20, [24] [25] [26] [29] [30] [31] 33, 36 Waldron, et al., 36 reported on 59 cases of spinal ependymomas and found that tumor grade was important with respect to recurrence and survival. Nazar, et al., 26 in their study of infratentorial ependymomas in children, suggested that histological criteria, in particular mitotic index, are influential prognostic criteria for outcome. However, they also note that other factors including subtotal resection or tumor invasion into the brainstem may be responsible for the poor outcome in tumors with a benign histological picture. On the other hand, Kricheff, et al., 19 found no correlation between histology and biological behavior in their review of 65 cases of intracranial ependymomas. Ross and Rubinstein 30 found no correlation between pathology and survival in 15 patients with malignant ependymomas. Fokes and Earle 12 also did not observe an association between histological grading and survival time in their review of 133 ependymomas. Similarly, Mørk and Løken 24 found histological classification to be of limited prognostic value in their study of 101 patients with ependymomas. Even myxopapillary ependymomas, which are benign histologically, have been known to recur and disseminate. In particular, there may be a tendency for late recurrence, especially with subtotal resection. 35 In this report, the histological subtypes significantly associated with dissemination were high-grade and myxo-papillary tumors. Most of the disseminated tumors from primary spinal lesions were myxopapillary (55%), whereas all the disseminated intracranial ependymomas were high grade on histological review. In contrast, the predominant histology in the nondisseminated population was low grade (82%). Although there have been previous reports showing an increased tendency for dissemination and recurrence among myxopapillary tumors, there has not been a previous association noted between high-grade lesions and dissemination. The risk ratio derived from the Cox proportional hazards multivariate model indicates that the high-grade and myxopapillary tumors were 5.6 and 3.6 times more likely to disseminate, respectively, than the low-grade tumors. In addition, the dissemination curves (Fig. 2 lower) revealed that high-grade tumors disseminated earlier than myxopapillary tumors. Thus, histology is an important prognostic factor with respect to dissemination. When compared to other variables in the multivariate analysis, histology exhibited the most profound effect. Therefore, patients with "high risk" histology (high-grade and myxopapillary tumors) should be followed with a heightened suspicion of dissemination and with a lower threshold for obtaining follow-up imaging studies.
Tumor Biology
Markers of proliferative activity are being used increasingly to gauge the malignant potential of tumors. Proliferation index analysis supplements conventional histological information and may provide a more thorough prognostic picture. Until recently, analysis of proliferation capacity was difficult and cumbersome because it required radioisotope injection, fresh or frozen tissue for bromodeoxyuridine analysis, and tedious cell counting. However, the advent of immunohistochemical techniques and the development of antibodies against cellular proliferation markers such as Ki-67 1,2,14,17 and the proliferating cell nuclear antigen 7 have revolutionized cellular proliferation analysis. These markers now appear to have a strong correlation with tumor grading and clinical outcome in patients with brain tumors. 2, 4, 7, 8, 17, 18, 23, 25, 27 The group with disseminated disease had a higher proliferation index than the group without disseminated disease (p = 0.02). This difference was most pronounced for the intracranial tumors and an association was suggested in the spinal tumors. In addition, there was a significant association between MIB-1 and tumor histology. Highgrade tumors exhibited higher proliferation indices as well as an increased probability of dissemination. It is possible that MIB-1 is simply a reflection of pathology and may not have an independent effect on dissemination per se. The multivariate analysis demonstrated that pathology was the most significant factor related to dissemination, whereas proliferation index was not. The significance of proliferation indices and their relationship to tumor histology requires further clarification.
It is of interest that the disseminated intracranial ependymomas were all high grade on histological review, exhibited the highest proliferation indices, produced the shortest duration of symptoms prior to diagnosis, and disseminated earlier. Thus, disseminated intracranial ependymomas may be inherently more aggressive tumors.
The significance of dissemination and its association with survival has not been specifically addressed previously. In our series, 31% of patients with disseminated tumors died compared to 7% with nondisseminated tumors (p = 0.04). Thus, risk factors that are predictive for dissemination may also reflect a worse prognosis.
Conclusions
In this report, we have attempted to define prognostic criteria for dissemination in ependymomas. Tumor dissemination occurred in 11.4% of our patients with CNS ependymomas and was significantly associated with increased mortality. The comparison between patients with disseminated and nondisseminated ependymomas revealed that patients at risk for dissemination of tumor during the course of their disease were relatively younger, did not undergo gross-total tumor resections, had high-grade or myxopapillary tumors, and may exhibit high proliferation indices. We recommend that patients fitting these criteria receive follow-up care with a heightened sense of suspicion for disseminated disease. The importance of total resection at the initial surgical attempt must again be emphasized because a patient with residual tumor is 5.3 times more likely to eventually suffer from disseminated disease. Therefore, we believe strongly that ependymomas must be treated aggressively and all possible attempts should be made to achieve gross-total resections.
